1. Home
  2. NEXA vs CGEM Comparison

NEXA vs CGEM Comparison

Compare NEXA & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexa Resources S.A.

NEXA

Nexa Resources S.A.

HOLD

Current Price

$7.67

Market Cap

741.7M

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$10.21

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXA
CGEM
Founded
1956
2016
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
741.7M
671.7M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
NEXA
CGEM
Price
$7.67
$10.21
Analyst Decision
Hold
Strong Buy
Analyst Count
5
8
Target Price
$6.20
$28.00
AVG Volume (30 Days)
342.5K
1.4M
Earning Date
10-30-2025
11-06-2025
Dividend Yield
1.27%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,839,970,000.00
N/A
Revenue This Year
$3.85
N/A
Revenue Next Year
$1.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.95
N/A
52 Week Low
$4.44
$5.68
52 Week High
$9.61
$13.33

Technical Indicators

Market Signals
Indicator
NEXA
CGEM
Relative Strength Index (RSI) 64.81 47.91
Support Level $7.11 $10.01
Resistance Level $8.44 $13.10
Average True Range (ATR) 0.38 0.99
MACD 0.03 -0.16
Stochastic Oscillator 61.03 2.59

Price Performance

Historical Comparison
NEXA
CGEM

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: